Since NKG2A was associated with the effectiveness of dasatinib, we probed the potential role of NKG2A-HLA-E interaction by first examining the levels of HLA-E in CD34+ HSCs isolated from healthy adults and from treatment-naive CML patients. Here, KLRC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.